Isorhamnetin alleviates ferroptosis-mediated colitis by activating the NRF2/HO-1 pathway and chelating iron
PMID: 38795598
Source: Int Immunopharmacol
Publication date:
2025-07-24
Year:
2024
Abstract
NULL